Compare SLNO & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLNO | WFRD |
|---|---|---|
| Founded | 1999 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 4.1B |
| IPO Year | 2014 | N/A |
| Metric | SLNO | WFRD |
|---|---|---|
| Price | $51.42 | $76.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $110.90 | $85.67 |
| AVG Volume (30 Days) | ★ 1.8M | 699.7K |
| Earning Date | 11-04-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.52 |
| Revenue | $98,675,000.00 | ★ $4,970,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $155.86 | N/A |
| P/E Ratio | ★ N/A | $13.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $41.50 | $36.74 |
| 52 Week High | $90.32 | $86.64 |
| Indicator | SLNO | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 59.41 |
| Support Level | $47.80 | $73.55 |
| Resistance Level | $53.10 | $78.04 |
| Average True Range (ATR) | 2.47 | 2.83 |
| MACD | 1.09 | 0.21 |
| Stochastic Oscillator | 79.48 | 82.72 |
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.